Member Info for Basser1

Another great find Leggster.
So it looks like the HREC review of Sareum’s CTN application will take place on 10 May at 10.00 am.

My shares bought this morning at 116.90 is also showing as a sell

Ahfam - great research re SDC1802. It’s surprising that the intention to send SDC1802 straight into clinical Cancer trials was not picked up at the half year investormeet. It could be a significant statement which results in clinical trials for 1802 starting sooner than we had thought. Nice find.

‘The phase1a part of the trial is expected to provide safety and dosing information applicable for any future trials in patients with other autoimmune deceases and potentially in patients with the acute respiratory systems of viral infections, should the company decide to progress such trials.’’

We only need success in one indication but a successful completion of safety phase1a dosing and the potential of wider autoimmune and respiratory applicability would surely be an attractive package for pharmas to buy in at this stage. I am expecting Pharma interest when phase 1a is completed.

Laz - yes lots of big pharmas based in Seville and I recall that some of the Phase 1/2 SRA 737 trials took place in Spain?

See link by Mafuta below

Yes and latest scientific paper attached that makes reference to SRA737.

https://assets.researchsquare.com/files/rs-1990572/v2/f190c381-2a90-497e-b8e7-9d97d5f76ae1.pdf?c=1671032681

Another recent report (Nov 2022) supporting the role of CHK1 inhibitors and Gemcitabane in treating Small Cell Lung Cancer.

If GSK/Sierra are still holding out on SRA 737 clinical data they should be publicly shamed that they are both doing the dirty on what is the biggest Cancer Charity in the World. Time for someone in the press to dig out a good story on the holding back of important data that can help save lives.

68 million shares in total. 33,162 shares traded today. Down 5%. Welcome to the crazy world of Aim.

15.5k share traded. They drop the price 5%. Not so long ago well over 150k shares traded and big buys the share price doesn’t move. What a fine bunch they are.

So if the 13k sell is an ISA transfer there should be a corresponding buy at near the same price. So ignoring the ISA trade it was Buys 17,391 and sells 14,250 yet there is a price drop os approx 5%.

Par for the course as usual. How they get away with it is beyond me.

Drop the SP on a couple of sells - stop the rise on muliple buys. Sick of this blatant manipulation. Needs investigating.

Sareum will obviously need to provide clarification asap if this is incorrect.

My only take on it possibly being accurate would be in relation to the company’s plans to participate in Covid and respiratory trials which if successful could be fast tracked?

If you include the earlier 2 buys it could be a date of 23/2/23. Interestingly that date is a Thursday. Lol.

Is it difficult to buy?

Nice to see these daily 10k buys - been everyday for some three weeks or more now.

Does Dr Stephen Parker’s short tweet on the weekend suggest that he was still in San Francisco at least two days after the JP Morgan conference finished? Sorry can’t post a copy as my Twitter Account is down.

Interesting read in the current climate. Note the dangers of not having watertight contract arrangements should a Pharma decide to shelve a Biotech’s asset. CPF’s contract with Sierra for SRA 737 is a classic example of what can go wrong.

https://www.rbccm.com/en/gib/biopharma/episode/biotech-and-big-pharma-blueprint-for-successful-partnership?listen

Can’t see Parker falling into that scenario. I expect these to be one to one talks at this stage, if only to ensure confidentiality.